Royal Bank of Canada’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Sell |
2,574
-10,551
| -80% | -$20.5K | ﹤0.01% | 6270 |
|
|
2025
Q1 | $14K | Buy |
13,125
+12,925
| +6,463% | +$13.8K | ﹤0.01% | 5663 |
|
|
2024
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 6626 |
|
|
2024
Q3 | $0 | Sell |
200
-469
| -70% | – | ﹤0.01% | 6856 |
|
|
2024
Q2 | $1K | Buy |
669
+446
| +200% | +$667 | ﹤0.01% | 6498 |
|
|
2024
Q1 | $0 | Sell |
223
-135
| -38% | – | ﹤0.01% | 6932 |
|
|
2023
Q4 | $0 | Buy |
358
+158
| +79% | – | ﹤0.01% | 6912 |
|
|
2023
Q3 | $0 | Sell |
200
-191
| -49% | – | ﹤0.01% | 6948 |
|
|
2023
Q2 | $0 | Buy |
391
+191
| +96% | – | ﹤0.01% | 7081 |
|
|
2023
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 6903 |
|
|
2022
Q4 | $0 | Sell |
200
-126
| -39% | – | ﹤0.01% | 7108 |
|
|
2022
Q3 | $0 | Buy |
326
+126
| +63% | – | ﹤0.01% | 7243 |
|
|
2022
Q2 | $0 | Sell |
200
-300
| -60% | – | ﹤0.01% | 7112 |
|
|
2022
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 6909 |
|
|
2021
Q4 | $3K | Hold |
500
| – | – | ﹤0.01% | 6808 |
|
|
2021
Q3 | $5K | Buy |
500
+100
| +25% | +$1K | ﹤0.01% | 6616 |
|
|
2021
Q2 | $4K | Buy |
+400
| New | +$4K | ﹤0.01% | 6623 |
|
|
2021
Q1 | – | Sell |
-3,300
| Closed | -$19K | – | 7020 |
|
|
2020
Q4 | $19K | Buy |
+3,300
| New | +$19K | ﹤0.01% | 5540 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$1K | – | 5943 |
|
|
2017
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5657 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6095 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$1K | – | 5925 |
|
|
2017
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5833 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 5790 |
|